Journal ArticleDOI
Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study.
Feng Yee Chang,James E. Peacock,Daniel M. Musher,Patricia Triplett,Brent B. Macdonald,Joseph M. Mylotte,Alice O'donnell,Marilyn M. Wagener,Victor L. Yu +8 more
TLDR
Nafcillin was superior to vancomycin in preventing bacteriologic failure (persistent bacteremia or relapse) for methicillin-susceptible S. aureus (MSSA) baiteremia following antistaphylococcal therapy, and most were relapses.About:
This article is published in Medicine.The article was published on 2003-09-01. It has received 501 citations till now. The article focuses on the topics: Bacteremia & Vancomycin.read more
Citations
More filters
Journal ArticleDOI
Comparative Effectiveness of Beta-lactams versus Vancomycin for Treatment of Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections among 122 Hospitals
Jennifer S. McDanel,Eli N. Perencevich,Daniel J. Diekema,Loreen A. Herwaldt,Tara C. Smith,Elizabeth A. Chrischilles,Jeffrey D. Dawson,Lan Jiang,Michihiko Goto,Marin L. Schweizer +9 more
TL;DR: For patients with MSSA bloodstream infections, beta-lactams are superior to vancomycin for definitive therapy but not for empiric treatment, specifically antistaphylococcal penicillins or cefazolin.
Journal ArticleDOI
Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia?
Mical Paul,Mical Paul,Noa Zemer-Wassercug,O. Talker,Y. Lishtzinsky,B. Lev,Zmira Samra,Zmira Samra,Leonard Leibovici,Leonard Leibovici,Jihad Bishara,Jihad Bishara +11 more
TL;DR: Treatment of MSSA bacteraemia with cefazolin is not significantly different from treatment with cloxacillin, while treatment with other beta-lactams, including second and third generation cephalosporins, might be associated with higher mortality.
Journal ArticleDOI
Phase II, Randomized, Double-Blind, Multicenter Study Comparing the Safety and Pharmacokinetics of Tefibazumab to Placebo for Treatment of Staphylococcus aureus Bacteremia
J. John Weems,James P. Steinberg,Scott G. Filler,John W. Baddley,G. Ralph Corey,Priya Sampathkumar,Lisa G. Winston,Joseph F. John,Christine J. Kubin,Rohit Talwani,Thomas Moore,Joseph Patti,Seth Hetherington,Michele Texter,Eric Wenzel,Violet A. Kelley,Vance G. Fowler +16 more
TL;DR: Tefibazumab was well tolerated, with a safety profile similar to those of other monoclonal antibodies, under development as adjunctive therapy for serious Staphylococcus aureus infections.
Journal ArticleDOI
Safety and Clinical Outcomes when Utilizing High-Dose (≥8 mg/kg) Daptomycin Therapy
TL;DR: Daptomycin was well tolerated and effective at doses of 8 mg/kg or higher in patients with gram-positive infections, and further prospective and comparative studies of daptomecin at doses greater than 6mg/kg are warranted.
Journal ArticleDOI
Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection
TL;DR: Clinical trials and experimental animal studies show high failure rates, and the use of trimethoprim-sulfamethoxazole for community-acquired MRSA infection should not be endorsed without further research.
References
More filters
Journal ArticleDOI
Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.
Fred C. Tenover,Robert D. Arbeit,Richard V. Goering,P. A. Mickelsen,Barbara E Murray,D. H. Persing,B. Swaminathan +6 more
TL;DR: This research presents a novel, scalable and scalable approach that allows for real-time assessment of the severity of the infection and its impact on patients’ health.
Journal ArticleDOI
CDC definitions for nosocomial infections, 1988
TL;DR: The Centers for Disease Control (CDC) developed a new set of definitions for surveillance of nosocomial infections as mentioned in this paper, which combine specific clinical findings with results of laboratory and other tests that include recent advances in diagnostic technology.
Journal ArticleDOI
The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults.
William A. Knaus,Douglas P. Wagner,Elizabeth A. Draper,Jack E. Zimmerman,Marilyn Bergner,Paulo G. Bastos,Carl A. Sirio,Donaldj Murphy,Ted Lotring,Anne M. Damiano +9 more
TL;DR: The overall predictive accuracy of the first-day APACHE III equation was such that, within 24 h ofICU admission, 95 percent of ICU admissions could be given a risk estimate for hospital death that was within 3 percent of that actually observed.
Journal ArticleDOI
New criteria for diagnosis of infective endocarditis : Utilization of specific echocardiographic findings. Duke Endocarditis Service
TL;DR: Application of the proposed new criteria increases the number of definite diagnoses and should be useful for more accurate diagnosis and classification of patients with suspected endocarditis and provide better entry criteria for epidemiologic studies and clinical trials.
Related Papers (5)
Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus
Vance G. Fowler,Helen W. Boucher,G. Ralph Corey,Elias Abrutyn,Adolf W. Karchmer,Mark E. Rupp,Donald P. Levine,Henry F. Chambers,Francis P. Tally,Gloria Vigliani,Christopher H. Cabell,Arthur Stanley Link,Ignace DeMeyer,Scott G. Filler,Marcus J. Zervos,Paul P. Cook,Jeffrey Parsonnet,Jack M. Bernstein,Connie S. Price,Graeme N. Forrest,Gerd Fätkenheuer,Marcelo Gareca,Susan J. Rehm,Hans Reinhardt Brodt,Alan D. Tice,Sara E. Cosgrove +25 more